MIF and neuroblastoma: Indeed, treatment with MD13 reduced the concentration of secreted MIF in the culture supernatant of neuroblastoma tumoroids, with a maximal reduction of 81–84 % after 48 h (Fig. 5b, Supplementary Fig. 7a).